PRIVIA HEALTH GROUP INC
PRVANASDAQTrading Snapshot
- Day Range
- $21.57 β $22.08
- 52-Week Range
- $18.92 β $28.82
- Volume (shares)
- 648,634
- Avg Volume (shares)
- β
- Shares Outstanding
- 127.7M
- Next Earnings
- 2026-11-05
Fundamentals Snapshot
- Annual Revenue
- $2.12B
- Last Q Revenue
- $633M
- P/E Ratio
- 97.1
- P/S Ratio
- 1.2x
- EPS (TTM)
- $0.22
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +3.1%
PRIVIA HEALTH GROUP INC
PRVAAbout PRIVIA HEALTH GROUP INC
Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Latest News & Updates

Privia Health Group: Operating Leverage Could Lead To Share Price Upside
Privia Health Group is rated BUY, supported by strong operating leverage and expanding value-based care, positioning for earnings upside. PRVA trades at a 48% discount to its five-year average forward EV/EBITDA, with 24%

Privia Health to Report Third Quarter 2026 Results on Thursday, November 5
ARLINGTON, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its third-quarter and nine-month periods ended September 30, 202

Anthem Blue Cross and Blue Shield in Virginia and Privia Health Reach New Agreement
RICHMOND, Va.--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in Virginia and Privia Health have reached a new agreement that will continue providing Anthem members with in-network access to Privia Medical Group phys

Reviewing Guardant Health (NASDAQ:GH) & Privia Health Group (NASDAQ:PRVA)
Privia Health Group (NASDAQ: PRVA - Get Free Report) and Guardant Health (NASDAQ: GH - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the s

Bank of New York Mellon Corp Purchases Shares of 2,892,536 Privia Health Group, Inc. $PRVA
Bank of New York Mellon Corp acquired a new stake in Privia Health Group, Inc. (NASDAQ: PRVA) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commiss

Deutsche Bank AG Makes New $6.02 Million Investment in Privia Health Group, Inc. $PRVA
Deutsche Bank AG purchased a new stake in shares of Privia Health Group, Inc. (NASDAQ: PRVA) in the second quarter, according to its most recent 13F filing with the SEC. The fund purchased 234,049 shares of the company's